First pediatric PAH therapy approved in EU

Actelion’s pediatric dispersible formulation of Tracleer (bosentan) for the treatment of pulmonary arterial hypertension (PAH) has been approved in the EU. The approval...

Pfizer triumphs at environmental awards

Pfizer has been recognised as a leader in environmental excellence at the recent Business Commitment to the Environment (BCE) awards. Twelve companies received recognition...

CORRECTION: MabThera recommended in Scotland

Scottish physicians are now able to prescribe MabThera (rituximab) on the NHS, following a positive recommendation by the Scottish Medicines Consortium (SMC). MabThera was...

GPs need swine flu guidance

A poll of GPs by has revealed that, so far, only 9% of GPs in the UK have been given regular, clear and concise...

Tamiflu discount for poorer countries

Roche is to provide its antiviral Tamiflu at a lower price to developing countries as part of a new initiative. Under the Tamiflu Reserves...

Viruses resistant to Tamiflu identified

Several cases of the H1N1 ‘swine flu’ virus have emerged that are resistant to antiviral drug Tamiflu (oseltaminvir). WHO has been informed by...

Novo Nordisk launches Victoza in UK

Novo Nordisk’s Victoza is now available for type 2 diabetes patients in the UK, following EU approval. Victoza is the first once-daily human Glucagon-like...

Novartis joins fight against malaria

Novartis has become the first healthcare company to join United Against Malaria (UAM), a pan-Africa campaign to end malaria-related deaths and suffering by 2015....

Best-selling drugs cheaper in Europe

European prices of 170 best-selling drugs averaged 40% less than US prices in 2008, recent research has revealed. Within Europe, it was found,...

Study confirms Cervarix efficacy

The largest efficacy trial of a cervical cancer vaccine has shown that Cervarix protects against the five most common cancer-causing virus types. The...

Latest articles

Career close-up: Alessandra Dorigo

Career close-up: Alessandra Dorigo

Pf talks to Alessandra Dorigo, who was recently appointed General Manager UK, Ireland, Baltics and Nordics at Advanced Accelerator Applications (AAA), a Novartis company. Tell...
JCVI advises that all UK 16- and 17-year-olds should be offered COVID-19 vaccine

JCVI advises all UK 16- and 17-year-olds should be offered COVID-19 vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice that all 16 to 17-year-olds should be offered a first dose of the...
OPEN Health acquires medical communications agency Spirit

OPEN Health acquires medical communications agency Spirit

OPEN Health has announced the acquisition of North West UK-based medical communications agency Spirit. A statement from OPEN Health stated that integrating the Spirit business...

Popular articles

MHRA approves first immunotherapy treatment for mesothelioma

MHRA approves first immunotherapy treatment for mesothelioma   

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the combination of nivolumab plus ipilimumab for the first-line treatment of adult patients with...
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Challenges in recruiting during the pandemic

Challenges in recruiting during the pandemic

Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
Syneos Health and Aetion partner to offer real-world evidence solutions

Syneos Health and Aetion partner to offer real-world evidence solutions

Syneos Health and Aetion have announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes. The partnership...
Career close-up: Alessandra Dorigo

Career close-up: Alessandra Dorigo

Pf talks to Alessandra Dorigo, who was recently appointed General Manager UK, Ireland, Baltics and Nordics at Advanced Accelerator Applications (AAA), a Novartis company. Tell...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription